Kurzgesagt – In a Nutshell
Уровень B2· 861 слово
In the last few years Ozempic or Mounjaro managed to make millions of people lose massive amounts of weight with seemingly only mild side effects.
More than one in eight US adults have tried the drugs, and for the first time in history the country’s obesity rate actually fell.
At the end of 2025 the WHO added GLP-1 drugs to its Essential Medicines List for diabetics and released guidelines on how to use it for obesity.
For the first time ever, we have a medication that reliably, quickly and seemingly safely can make people lose weight.
Sometimes massive amounts of weight. But as with most things related to nutrition, health and weight loss these medications are controversial.
There are many aspects to GLP-1s, but we will focus on one today: The potential medical revolution these drugs could mean for obesity, one of the most deadly chronic diseases of our time that over one billion people suffer from and that remains largely unsolved and underfunded.
It turns out GLP-1 drugs are the first effective medical treatment for obesity in medical history.
The Obesity Trap In 2025 more than half of Europeans were either overweight or obese, plus one in three children.
And in many countries like the US, Mexico, Chile or Saudi Arabia the numbers are even worse. Today this kills almost 4 million people each year and if trends continue, by 2050 one in three adults on Earth will be obese and half of humanity will be overweight.
When hearing the word obese most people think of the extreme ends of the spectrum, but this is not correct.
It’s not very helpful that the definition of obese is a bit vague because bodies are pretty different.
So it can be a BMI of over 30, your waist to hip ratio or a body fat percentage of over 25% for men and over 32% for women.
